Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress
Mithra to hold joint symposium with partner Gedeon Richter on 11 October Four leading experts…
News
IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2023
Aggregated presentation by day and by market Name of issuer Identification code of issuer (Legal…
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
CHINO HILLS, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC…
Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates
FORT WORTH, TX, Oct. 10, 2023 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,”…
Cellebrite Experts to Moderate Human Trafficking Panel, Present on Digital Intelligence at International Association of Chiefs of Police (IACP) Expo and Conference
TYSONS CORNER, Va., PETAH TIKVA, Israel and SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) —…
Avantax Welcomes Financial Advisor Bob Ervolina and his New York-based Lifetime Wealth Management Group
25-year industry veteran advisor attracted by close-knit Avantax Community, ease of doing business, and opportunities…
New Frontier Group Achieves ISO 9001 Certification
FOOTHILL RANCH, CA, Oct 10, 2023 – (ACN Newswire) – New Frontier Group, a cost…
ŌURA Debuts Stress Management Features and Brushed Titanium Finish
Building on its success in sleep, ŌURA empowers members to manage stress and build resilience…
CDISC and DiMe Partner to Advance DHT Data Standards to Improve Health Outcomes
AUSTIN, Texas & BOSTON–(BUSINESS WIRE)–Clinical Data Interchange Standards Consortium (CDISC) and Digital Medicine Society (DiMe)…
New Study to Explore AI’s Role, Next-Generation Virtual Classrooms, in Shaping the Future of Higher Education
Casey Green, Founder of The Campus Computing Project to Publish Research on the Impact of…
5G Network Technology and High-Speed Data Communications Fueling Growth in the RAN Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Radio Access Network – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s…
Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society
-24-Month Open Label Extension Data from HOPE-2 Study Supports CAP-1002’s Sustained Efficacy and Safety in…
Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society
-24-Month Open Label Extension Data from HOPE-2 Study Supports CAP-1002’s Sustained Efficacy and Safety in…
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership Team CINCINNATI, Oct….
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership Team CINCINNATI, Oct….
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…